NovaBridge Biosciences Statistics
Total Valuation
NBP has a market cap or net worth of $459.91 million. The enterprise value is $297.78 million.
Important Dates
The next estimated earnings date is Tuesday, March 17, 2026, after market close.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NBP has 115.27 million shares outstanding. The number of shares has decreased by -0.61% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 115.27M |
| Shares Change (YoY) | -0.61% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 5.61% |
| Owned by Institutions (%) | 20.75% |
| Float | 59.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.66 |
| P/TBV Ratio | 2.34 |
| P/FCF Ratio | 10.56 |
| P/OCF Ratio | 10.55 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 6.84 |
Financial Position
The company has a current ratio of 22.82, with a Debt / Equity ratio of 0.02.
| Current Ratio | 22.82 |
| Quick Ratio | 22.65 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.08 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.46% and return on invested capital (ROIC) is -10.82%.
| Return on Equity (ROE) | -18.46% |
| Return on Assets (ROA) | -10.36% |
| Return on Invested Capital (ROIC) | -10.82% |
| Return on Capital Employed (ROCE) | -19.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.25M |
| Employee Count | 32 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +276.42% in the last 52 weeks. The beta is 1.64, so NBP's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | +276.42% |
| 50-Day Moving Average | 4.50 |
| 200-Day Moving Average | 2.77 |
| Relative Strength Index (RSI) | 46.08 |
| Average Volume (20 Days) | 418,858 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -38.16M |
| Pretax Income | -39.99M |
| Net Income | -39.99M |
| EBITDA | -38.09M |
| EBIT | -38.16M |
| Earnings Per Share (EPS) | -$0.49 |
Full Income StatementBalance Sheet
The company has $165.61 million in cash and $3.48 million in debt, giving a net cash position of $162.13 million or $1.41 per share.
| Cash & Cash Equivalents | 165.61M |
| Total Debt | 3.48M |
| Net Cash | 162.13M |
| Net Cash Per Share | $1.41 |
| Equity (Book Value) | 196.73M |
| Book Value Per Share | 2.41 |
| Working Capital | 160.29M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $43.59 million and capital expenditures -$46,000, giving a free cash flow of $43.55 million.
| Operating Cash Flow | 43.59M |
| Capital Expenditures | -46,000 |
| Free Cash Flow | 43.55M |
| FCF Per Share | $0.38 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
